These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19910632)

  • 41. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
    Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.
    Landskroner-Eiger S; Qian B; Muise ES; Nawrocki AR; Berger JP; Fine EJ; Koba W; Deng Y; Pollard JW; Scherer PE
    Clin Cancer Res; 2009 May; 15(10):3265-76. PubMed ID: 19447867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
    Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
    Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
    Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac-derived adiponectin induced by long-term insulin treatment ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling.
    Pei H; Qu Y; Lu X; Yu Q; Lian K; Liu P; Yan W; Liu J; Ma Y; Liu Y; Li C; Li W; Lau WB; Zhang H; Tao L
    Basic Res Cardiol; 2013 Jan; 108(1):322. PubMed ID: 23262803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions.
    Thakran S; Zhang Q; Morales-Tirado V; Steinle JJ
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):177-84. PubMed ID: 25525174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
    Souza SC; Yamamoto MT; Franciosa MD; Lien P; Greenberg AS
    Diabetes; 1998 Apr; 47(4):691-5. PubMed ID: 9568706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products.
    Marx N; Walcher D; Ivanova N; Rautzenberg K; Jung A; Friedl R; Hombach V; de Caterina R; Basta G; Wautier MP; Wautiers JL
    Diabetes; 2004 Oct; 53(10):2662-8. PubMed ID: 15448098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Role of adiponectin and its receptors in anti-atherosclerotic effects of pioglitazone on ApoE knocked out mice].
    Da-Wa CR; Zhao F; Qi YF; Chen LZ; Huo Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 41(2):174-8. PubMed ID: 19377625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance.
    He J; Xu C; Kuang J; Liu Q; Jiang H; Mo L; Geng B; Xu G
    Metabolism; 2015 Jul; 64(7):826-36. PubMed ID: 25825274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation.
    Biscetti F; Straface G; Arena V; Stigliano E; Pecorini G; Rizzo P; De Angelis G; Iuliano L; Ghirlanda G; Flex A
    Cardiovasc Diabetol; 2009 Sep; 8():49. PubMed ID: 19737384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
    Shen X; Li H; Li W; Wu X; Ding X
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.
    Nishimura M; Izumiya Y; Higuchi A; Shibata R; Qiu J; Kudo C; Shin HK; Moskowitz MA; Ouchi N
    Circulation; 2008 Jan; 117(2):216-23. PubMed ID: 18158361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats.
    Li P; Xu X; Zheng Z; Zhu B; Shi Y; Liu K
    Curr Eye Res; 2011 Jul; 36(7):673-9. PubMed ID: 21599458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.
    Li Y; Li L; Li Z; Sheng J; Zhang X; Feng D; Zhang X; Yin F; Wang A; Wang F
    Biochim Biophys Acta; 2016 Oct; 1860(10):2137-47. PubMed ID: 27233450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans.
    Phillips SA; Kung J; Ciaraldi TP; Choe C; Christiansen L; Mudaliar S; Henry RR
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E767-73. PubMed ID: 19622782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.
    Gonon AT; Bulhak A; Labruto F; Sjöquist PO; Pernow J
    Basic Res Cardiol; 2007 Jan; 102(1):80-9. PubMed ID: 16900441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
    Wang J; Lin J; Kaiser U; Wohlfart P; Hammes HP
    Acta Diabetol; 2017 Apr; 54(4):383-392. PubMed ID: 28070752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice.
    Mohapatra J; Sharma M; Singh S; Chatterjee A; Swain P; Balaraman R; Patel PR; Jain MR
    Pharmacology; 2009; 84(4):203-10. PubMed ID: 19738399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.